Psychedelic is called as psychedelics, which is class of hallucinogenic drugs including both classic hallucinogens and dissociative drugs which are used recreationally, to enhance the sensory perception, elevate the mood swings, energy level promoting spiritual experiences, and thought process. These drugs have been used experimentally for psychological treatment.
Increase in prevalence of depression across the globe is the key driving factor which is expected to boost the global psychedelic drugs market growth. Furthermore, change in lifestyle and requirement for enhanced and better life quality will positively contribute the market growth. Also, increase in research and development activities is expected to propel the market growth during this analysis period. Moreover, increase in dependency on psychedelic drugs for treatment of depression is expected to propel the global psychedelic drugs market growth during this forecast period.
However, stringent rules and regulations imposed by government to commercialize psychedelic drugs is the major challenging factor which is expected to hinder the global psychedelic drugs market growth. Also, poor efficiency and safety profile of existing intervention will affect the market growth over the forecast period.
Global Psychedelic Drugs Market is segmented into drug type such as Lysergic Acid Diethylamide (LSD), 3,4-Methyl?Enedioxy?Methamphetamine (Ecstasy), Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Ketamine, Ayahuasca, Salvia, Psilocybin, and Others, by route of administration such as Oral, Injectable, and Inhalation, by distribution channel such as Direct Retailers, Online Pharmacies, and Others. Further, market is segmented into End –Users such as Hospitals, Homecare, Specialty Clinics, and others.
Also, Global Psychedelic Drugs Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key players are discussed in this report such as AstraZeneca,, COMPASS,, Klarisana, F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited,, Dr. Reddy’s Laboratories Ltd,, Pfizer Inc,, Merck & Co., Inc, ,and Lundbeck A/S
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5.1 Y-o-Y Growth Comparison, By Drug Type
5.2 Global Psychedelic Drugs Market Share Analysis, By Drug Type
5.3 Global Psychedelic Drugs Market Size and Forecast, By Drug Type
5.3.1 Lysergic Acid Diethylamide (LSD)
5.3.2 3,4-MethylEnedioxyMethamphetamine (Ecstasy)
5.3.3 Phencyclidine
5.3.4 Gamma Hydroxybutyric Acid (GHB),
5.3.5 Ketamine
5.3.6 Ayahuasca
5.3.7 Salvia
5.3.8 Psilocybin
5.3.9 Others
6.1 Y-o-Y Growth Comparison, By Route of Administration
6.2 Global Psychedelic Drugs Market Share Analysis, By Route of Administration
6.3 Global Psychedelic Drugs Market Size and Forecast, By Route of Administration
6.3.1 Oral
6.3.2 Injectable
6.3.3 Inhalation
7.1 Y-o-Y Growth Comparison, By Distribution Channel
7.2 Global Psychedelic Drugs Market Share Analysis, By Distribution Channel
7.3 Global Psychedelic Drugs Market Size and Forecast, By Distribution Channel
7.3.1 Direct Retailers
7.3.2 Online Pharmacies
7.3.3 Others
8.1 Y-o-Y Growth Comparison, By End User
8.2 Global Psychedelic Drugs Market Share Analysis, By End User
8.3 Global Psychedelic Drugs Market Size and Forecast, By End User
8.3.1 Hospitals
8.3.2 Homecare
8.3.3 Speciality Clinics
8.3.4 Others
9.1 Global Psychedelic Drugs Market Share Analysis, By Region
9.2 Global Psychedelic Drugs Market Share Analysis, By Region
9.3 Global Psychedelic Drugs Market Size and Forecast, By Region
10.1 Introduction
10.2 North America Psychedelic Drugs Product Market Share Analysis, By Drug Type
10.3 North America Psychedelic Drugs Product Market Size and Forecast, By Route of Administration
10.4 North America Psychedelic Drugs Product Market Size and Forecast, By Distribution Channel
10.5 North America Psychedelic Drugs Product Market Size and Forecast, By End User
10.6 North America Psychedelic Drugs Product Market Size and Forecast, By Country
10.6.1 U.S.
10.6.2 Canada
10.6.3 Mexico
11.1 Introduction
11.2 Europe Psychedelic Drugs Product Market Share Analysis, By Drug Type
11.3 Europe Psychedelic Drugs Product Market Size and Forecast, By Route of Administration
11.4 Europe Psychedelic Drugs Product Market Size and Forecast, By Distribution Channel
11.5 Europe Psychedelic Drugs Product Market Size and Forecast, By End User
11.6 Europe Psychedelic Drugs Product Market Size and Forecast, By Country
11.6.1 Germany
11.6.2 France
11.6.3 UK
11.64. Rest of Europe
12.1 Introduction
12.2 Asia Pacific Psychedelic Drugs Product Market Share Analysis, By Drug Type
12.3 Asia Pacific Psychedelic Drugs Product Market Size and Forecast, By Route of Administration
12.4 Asia Pacific Psychedelic Drugs Product Market Size and Forecast, By Distribution Channel
12.5 Asia Pacific Psychedelic Drugs Product Market Size and Forecast, By End User
12.6 Asia Pacific Psychedelic Drugs Product Market Size and Forecast, By Country
12.6.1 China
12.6.2 Japan
12.6.3 India
12.6.4. Rest of Asia Pacific
13.1 Introduction
13.2 Latin America Psychedelic Drugs Product Market Share Analysis, By Drug Type
13.3 Latin America Psychedelic Drugs Product Market Size and Forecast, By Route of Administration
13.4 Latin America Psychedelic Drugs Product Market Size and Forecast, By Distribution Channel
13.5 Latin America Psychedelic Drugs Product Market Size and Forecast, By End User
13.6 Latin America Psychedelic Drugs Product Market Size and Forecast, By Country
14.1 Introduction
14.2 Middle East Psychedelic Drugs Product Market Share Analysis, By Drug Type
14.3 Middle East Psychedelic Drugs Product Market Size and Forecast, By Route of Administration
14.4 Middle East Psychedelic Drugs Product Market Size and Forecast, By Distribution Channel
14.5 Middle East Psychedelic Drugs Product Market Size and Forecast, By End User
14.6 Middle East Psychedelic Drugs Product Market Size and Forecast, By Country
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies
16.8.1 Overview
16.8.2 Offerings
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies
16.9.1 Overview
16.9.2 Offerings
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies
